Pfizer’s “Viva Viagra” Ad Skips A Beat On Safety Risks; FDA Issues Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency faces industry pressure to define Internet ad regulations.
You may also be interested in...
Patient Who Wouldn't Be Here Without Axcan's Photofrin Should Disappear Now, FDA Says
Web videos featuring overblown patient testimonials prove an easy target for DDMAC.
Patient Who Wouldn't Be Here Without Axcan's Photofrin Should Disappear Now, FDA Says
Web videos featuring overblown patient testimonials prove an easy target for DDMAC.
FDA’s Advertising Enforcement Turns Its Focus To YouTube, ADHD Drugs
FDA's spate of five promotional citations to manufacturers of attention deficit/hyperactivity disorder drugs signals that the agency intends to remain vigilant in oversight of new media